{"transactions":[{"id":1716478,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-11T16:56:58.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These option shares were part of a stock option grant covering 85,713 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant vested on May 30, 2022; and 35% of the total shares subject to the stock option grant vested on May 30, 2023, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":22427,"derivative":{"exercise_price":0.14,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-23-058082","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919123058082/doc4.xml","form_type":"4"}},{"id":1716477,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-11T16:56:58.000Z","date":"2023-12-11","kind":"exercise","planned":false,"acquired":true,"shares":14000,"price":0.14,"value":1960.0,"ownership":{"direct":true},"balance_after":77500,"source":{"system":"sec-edgar","filing":"0001209191-23-058082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919123058082/doc4.xml","form_type":"4"}},{"id":1734854,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2023-11-20T16:55:48.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These option shares were part of a stock option grant covering 85,713 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant vested on May 30, 2022; and 35% of the total shares subject to the stock option grant vested on May 30, 2023, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":36427,"derivative":{"exercise_price":0.14,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-056086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919123056086/doc4.xml","form_type":"4"}},{"id":1734853,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-20T16:55:48.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":0.14,"value":2100.0,"ownership":{"direct":true},"balance_after":63500,"source":{"system":"sec-edgar","filing":"0001209191-23-056086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919123056086/doc4.xml","form_type":"4"}},{"id":2432466,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2022-01-19T17:42:09.000Z","date":"2022-01-14","kind":"exercise","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These option shares were part of a stock option grant covering 85,713 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant will vest on May 30, 2022; and 35% of the total shares subject to the stock option grant will vest on May 30, 2023, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":51427,"derivative":{"exercise_price":0.14,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001209191-22-003785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919122003785/doc4.xml","form_type":"4"}},{"id":2432465,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2022-01-19T17:42:09.000Z","date":"2022-01-14","kind":"exercise","acquired":false,"shares":1714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20% of the total shares subject to the stock option grant vested on December 22, 2021; 20% of the total shares subject to the stock option grant will vest on December 22, 2022; 25% of the total shares subject to the stock option grant will vest on December 22, 2023; and 35% of the total shares subject to the stock option grant will vest on December 22, 2024, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":6857,"derivative":{"exercise_price":0.21,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":1714},"source":{"system":"sec-edgar","filing":"0001209191-22-003785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919122003785/doc4.xml","form_type":"4"}},{"id":2432464,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-19T17:42:09.000Z","date":"2022-01-14","kind":"exercise","acquired":true,"shares":1,"price":0.14,"value":0.14,"ownership":{"direct":true},"balance_after":48500,"source":{"system":"sec-edgar","filing":"0001209191-22-003785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919122003785/doc4.xml","form_type":"4"}},{"id":2432463,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-19T17:42:09.000Z","date":"2022-01-14","kind":"exercise","acquired":true,"shares":1714,"price":0.21,"value":359.94,"ownership":{"direct":true},"balance_after":48499,"source":{"system":"sec-edgar","filing":"0001209191-22-003785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919122003785/doc4.xml","form_type":"4"}},{"id":2573422,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-10T17:48:38.000Z","date":"2021-09-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025."}],"balance_after":20000,"derivative":{"exercise_price":4.31,"expiration_date":"2031-09-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-055530","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919121055530/doc4.xml","form_type":"4"}},{"id":2626127,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":96259,"kind":"person","name":"Rhode Peter","position":1,"cik":"0001866276","reported_name":"Rhode Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-07-23T19:30:47.000Z","date":"2021-07-22","kind":"purchase","acquired":true,"shares":12500,"price":8,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share."}],"balance_after":46785,"source":{"system":"sec-edgar","filing":"0001209191-21-048082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866276/000120919121048082/doc4.xml","form_type":"4"}}]}